IBCP Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
["Not a good buy right now for an impatient entry: the stock is extended/overbought short-term and sitting just below near-term resistance (~36.88), which raises pullback risk.", "Trend is bullish longer-term (stacked moving averages + positive MACD), but near-term probability skew suggests a small dip over the next day/week before the broader monthly upside plays out.", "Options open interest is heavily put-skewed (bearish/protective positioning), which is a sentiment headwind for an immediate chase at current levels."]
["Trend: Bullish (SMA_5 > SMA_20 > SMA_200), indicating a solid uptrend across timeframes.", "Momentum: MACD histogram is positive (0.247) and expanding, supporting continuation of the uptrend.", "Overbought/extension: RSI(6) at ~77.98 indicates the stock is stretched in the short term (conditions consistent with a near-term cooldown).", "Levels: Pivot 35.58; key resistance R1 36.88 (price 36.68 is close), then R2 37.68; supports at 34.28 and 33.48.", "Pattern-based forward look: Similar-pattern stats imply ~60% chance of -1.46% next day, -0.89% next week, but +9.16% next month\u2014near-term chop/pullback risk despite constructive 1-month setup."]
["Technicals remain broadly bullish (moving average stack + positive MACD), supporting the intermediate trend.", "Analyst price targets were recently raised (Piper Sandler to $39; KBW to $37), implying incremental confidence in outlook.", "Q4 loan growth described as solid and asset quality metrics \u201cbenign\u201d per the latest analyst commentary."]
and price sitting just under resistance (~36.
reduce the attractiveness of buying immediately.", "Options open interest is heavily put-skewed (put/call OI 4.1), which can reflect cautious sentiment/hedging demand.", "Revenue declined YoY in the latest quarter, and operating expenses were cited as a drag (PPNR shortfall) in recent analyst notes.", "No news catalysts in the past week to provide an immediate upside trigger."]
["Latest quarter: 2025/Q4.", "Revenue: $47.42M, down 7.63% YoY (top-line contraction).", "Net income: $18.57M, up 0.60% YoY (slight improvement despite lower revenue).", "EPS: $0.89, up 2.30% YoY (modest per-share growth).", "Overall read: Profitability held up better than revenue, but growth quality is mixed given the YoY revenue decline."]
["Recent changes: Both Piper Sandler and Keefe Bruyette raised price targets (to $39 and $37, respectively) while maintaining Neutral/Market Perform stances.", "Street \u201cpros\u201d view: Solid loan growth and benign asset quality; results characterized as generally strong aside from expenses.", "Street \u201ccons\u201d view: Higher operating expenses/PPNR shortfall limits enthusiasm; ratings remain neutral despite higher targets (suggesting limited upside vs risk at current levels).", "Influential/political flows: No recent congress trading data available; hedge funds and insiders are both reported as Neutral with no significant recent trends."]
